Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab.

Pianta Taleng CM Melong; K Lauper; B Gilbert; T Cunningham; R Guemara; L Brulhart; D Dan; D Courvoisier; A Finckh

doi:10.1136/rmdopen-2021-001711

Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab.

Pianta Taleng CM Melong, K Lauper, B Gilbert, T Cunningham, R Guemara, L Brulhart, D Dan, D Courvoisier, A Finckh

Division of Musculoskeletal & Dermatological Sciences

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	RMD Open
DOIs	https://doi.org/10.1136/rmdopen-2021-001711
Publication status	Published - 7 Dec 2021

Access to Document

10.1136/rmdopen-2021-001711

Cite this

@article{fff3a95609644db38bb2a8937b5fbb16,

title = "Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab.",

author = "Melong, {Pianta Taleng CM} and K Lauper and B Gilbert and T Cunningham and R Guemara and L Brulhart and D Dan and D Courvoisier and A Finckh",

year = "2021",

month = dec,

day = "7",

doi = "10.1136/rmdopen-2021-001711",

language = "Undefined",

journal = "RMD Open",

issn = "2056-5933",

publisher = "BMJ ",

}

TY - JOUR

T1 - Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab.

AU - Melong, Pianta Taleng CM

AU - Lauper, K

AU - Gilbert, B

AU - Cunningham, T

AU - Guemara, R

AU - Brulhart, L

AU - Dan, D

AU - Courvoisier, D

AU - Finckh, A

PY - 2021/12/7

Y1 - 2021/12/7

UR - http://europepmc.org/abstract/med/34862310

U2 - 10.1136/rmdopen-2021-001711

DO - 10.1136/rmdopen-2021-001711

M3 - Article

C2 - 34862310

SN - 2056-5933

JO - RMD Open

JF - RMD Open

ER -

Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab.

Access to Document

Other files and links

Cite this